Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.81 |
Intermediate Similarity |
NPD7255 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD7559 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD5641 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD4084 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7363 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7327 |
Intermediate Similarity |
NPD5562 |
Approved |
0.7327 |
Intermediate Similarity |
NPD8149 |
Discontinued |
0.7327 |
Intermediate Similarity |
NPD5561 |
Approved |
0.7304 |
Intermediate Similarity |
NPD2843 |
Phase 2 |
0.7304 |
Intermediate Similarity |
NPD2845 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD6296 |
Discontinued |
0.7264 |
Intermediate Similarity |
NPD7891 |
Discontinued |
0.722 |
Intermediate Similarity |
NPD7617 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD3591 |
Approved |
0.7209 |
Intermediate Similarity |
NPD3592 |
Approved |
0.7207 |
Intermediate Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD3631 |
Phase 3 |
0.7194 |
Intermediate Similarity |
NPD3511 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD3106 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7280 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD7281 |
Phase 3 |
0.7137 |
Intermediate Similarity |
NPD3441 |
Approved |
0.7137 |
Intermediate Similarity |
NPD3442 |
Approved |
0.7129 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD6533 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD6063 |
Approved |
0.711 |
Intermediate Similarity |
NPD7225 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD7131 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD5025 |
Approved |
0.7087 |
Intermediate Similarity |
NPD6608 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD7174 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD8103 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD4083 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD6046 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD6645 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD3296 |
Phase 1 |
0.6987 |
Remote Similarity |
NPD7859 |
Phase 2 |
0.6986 |
Remote Similarity |
NPD4740 |
Approved |
0.6985 |
Remote Similarity |
NPD7608 |
Discontinued |
0.6981 |
Remote Similarity |
NPD6877 |
Discontinued |
0.6965 |
Remote Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7263 |
Phase 2 |
0.6952 |
Remote Similarity |
NPD7125 |
Discontinued |
0.6944 |
Remote Similarity |
NPD5102 |
Clinical (unspecified phase) |
0.6942 |
Remote Similarity |
NPD6045 |
Phase 3 |
0.6935 |
Remote Similarity |
NPD2821 |
Approved |
0.6919 |
Remote Similarity |
NPD7256 |
Discontinued |
0.6901 |
Remote Similarity |
NPD5071 |
Phase 2 |
0.6884 |
Remote Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.6884 |
Remote Similarity |
NPD7476 |
Discontinued |
0.6881 |
Remote Similarity |
NPD5966 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD4997 |
Clinical (unspecified phase) |
0.6858 |
Remote Similarity |
NPD7556 |
Discontinued |
0.6851 |
Remote Similarity |
NPD7025 |
Clinical (unspecified phase) |
0.6844 |
Remote Similarity |
NPD5519 |
Discontinued |
0.6842 |
Remote Similarity |
NPD7291 |
Discontinued |
0.6842 |
Remote Similarity |
NPD7821 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD7607 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD6365 |
Clinical (unspecified phase) |
0.6825 |
Remote Similarity |
NPD3634 |
Approved |
0.6825 |
Remote Similarity |
NPD3633 |
Approved |
0.681 |
Remote Similarity |
NPD4885 |
Approved |
0.681 |
Remote Similarity |
NPD6377 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD7729 |
Clinical (unspecified phase) |
0.6802 |
Remote Similarity |
NPD5773 |
Approved |
0.6802 |
Remote Similarity |
NPD5772 |
Approved |
0.6798 |
Remote Similarity |
NPD3912 |
Discontinued |
0.6791 |
Remote Similarity |
NPD7810 |
Phase 3 |
0.6791 |
Remote Similarity |
NPD7811 |
Phase 3 |
0.6789 |
Remote Similarity |
NPD6644 |
Discontinued |
0.6787 |
Remote Similarity |
NPD5914 |
Approved |
0.6782 |
Remote Similarity |
NPD2215 |
Approved |
0.6782 |
Remote Similarity |
NPD2216 |
Approved |
0.6781 |
Remote Similarity |
NPD6723 |
Discontinued |
0.6777 |
Remote Similarity |
NPD6656 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD4604 |
Approved |
0.6776 |
Remote Similarity |
NPD4605 |
Approved |
0.6773 |
Remote Similarity |
NPD5658 |
Approved |
0.6773 |
Remote Similarity |
NPD8027 |
Approved |
0.677 |
Remote Similarity |
NPD8318 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD7485 |
Phase 3 |
0.6766 |
Remote Similarity |
NPD7484 |
Phase 3 |
0.6759 |
Remote Similarity |
NPD6612 |
Phase 2 |
0.6752 |
Remote Similarity |
NPD6963 |
Approved |
0.6752 |
Remote Similarity |
NPD6964 |
Approved |
0.6748 |
Remote Similarity |
NPD6211 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD3153 |
Approved |
0.6746 |
Remote Similarity |
NPD3154 |
Approved |
0.674 |
Remote Similarity |
NPD3437 |
Discontinued |
0.6739 |
Remote Similarity |
NPD7426 |
Phase 1 |
0.6735 |
Remote Similarity |
NPD8091 |
Phase 3 |
0.6731 |
Remote Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.6726 |
Remote Similarity |
NPD7178 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD7820 |
Phase 3 |
0.6717 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6712 |
Remote Similarity |
NPD5645 |
Phase 3 |
0.6699 |
Remote Similarity |
NPD7479 |
Phase 2 |
0.6698 |
Remote Similarity |
NPD4979 |
Clinical (unspecified phase) |
0.6697 |
Remote Similarity |
NPD6795 |
Clinical (unspecified phase) |
0.6684 |
Remote Similarity |
NPD5811 |
Approved |
0.6683 |
Remote Similarity |
NPD5967 |
Approved |
0.6683 |
Remote Similarity |
NPD4498 |
Clinical (unspecified phase) |
0.6682 |
Remote Similarity |
NPD4413 |
Clinical (unspecified phase) |
0.6682 |
Remote Similarity |
NPD4157 |
Discontinued |
0.6682 |
Remote Similarity |
NPD3398 |
Discontinued |
0.6682 |
Remote Similarity |
NPD6519 |
Phase 2 |
0.668 |
Remote Similarity |
NPD8463 |
Approved |
0.6667 |
Remote Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3802 |
Phase 3 |
0.6652 |
Remote Similarity |
NPD7452 |
Approved |
0.6652 |
Remote Similarity |
NPD7453 |
Approved |
0.6652 |
Remote Similarity |
NPD7222 |
Phase 2 |
0.6651 |
Remote Similarity |
NPD5896 |
Clinical (unspecified phase) |
0.6651 |
Remote Similarity |
NPD7546 |
Discontinued |
0.6651 |
Remote Similarity |
NPD3416 |
Discontinued |
0.6651 |
Remote Similarity |
NPD5582 |
Discontinued |
0.6651 |
Remote Similarity |
NPD7877 |
Suspended |
0.665 |
Remote Similarity |
NPD5312 |
Approved |
0.665 |
Remote Similarity |
NPD1293 |
Approved |
0.665 |
Remote Similarity |
NPD5847 |
Phase 1 |
0.665 |
Remote Similarity |
NPD5313 |
Approved |
0.665 |
Remote Similarity |
NPD3965 |
Phase 1 |
0.6649 |
Remote Similarity |
NPD4123 |
Phase 3 |
0.6638 |
Remote Similarity |
NPD7805 |
Phase 3 |
0.6636 |
Remote Similarity |
NPD5547 |
Clinical (unspecified phase) |
0.6636 |
Remote Similarity |
NPD4539 |
Phase 1 |
0.6636 |
Remote Similarity |
NPD6874 |
Approved |
0.6635 |
Remote Similarity |
NPD6793 |
Clinical (unspecified phase) |
0.6633 |
Remote Similarity |
NPD6060 |
Clinical (unspecified phase) |
0.6624 |
Remote Similarity |
NPD6982 |
Phase 2 |
0.6616 |
Remote Similarity |
NPD7110 |
Phase 1 |
0.6616 |
Remote Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.6609 |
Remote Similarity |
NPD8311 |
Discontinued |
0.6607 |
Remote Similarity |
NPD4206 |
Approved |
0.6604 |
Remote Similarity |
NPD3349 |
Phase 2 |
0.6604 |
Remote Similarity |
NPD5620 |
Clinical (unspecified phase) |
0.6601 |
Remote Similarity |
NPD6457 |
Approved |
0.6597 |
Remote Similarity |
NPD7596 |
Clinical (unspecified phase) |
0.6597 |
Remote Similarity |
NPD7153 |
Discontinued |
0.6594 |
Remote Similarity |
NPD7858 |
Clinical (unspecified phase) |
0.6589 |
Remote Similarity |
NPD5587 |
Approved |
0.6583 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6581 |
Remote Similarity |
NPD7589 |
Clinical (unspecified phase) |
0.6574 |
Remote Similarity |
NPD8249 |
Clinical (unspecified phase) |
0.657 |
Remote Similarity |
NPD3793 |
Phase 3 |
0.6569 |
Remote Similarity |
NPD5183 |
Approved |
0.6569 |
Remote Similarity |
NPD8017 |
Clinical (unspecified phase) |
0.6569 |
Remote Similarity |
NPD5186 |
Approved |
0.6569 |
Remote Similarity |
NPD8016 |
Phase 3 |
0.6568 |
Remote Similarity |
NPD6494 |
Phase 2 |
0.6558 |
Remote Similarity |
NPD7262 |
Phase 1 |
0.6555 |
Remote Similarity |
NPD5192 |
Clinical (unspecified phase) |
0.6553 |
Remote Similarity |
NPD5938 |
Phase 3 |
0.6552 |
Remote Similarity |
NPD2341 |
Discontinued |
0.6547 |
Remote Similarity |
NPD4154 |
Approved |
0.6545 |
Remote Similarity |
NPD956 |
Clinical (unspecified phase) |
0.6544 |
Remote Similarity |
NPD6621 |
Clinical (unspecified phase) |
0.6538 |
Remote Similarity |
NPD7710 |
Clinical (unspecified phase) |
0.6533 |
Remote Similarity |
NPD683 |
Approved |
0.653 |
Remote Similarity |
NPD1200 |
Approved |
0.653 |
Remote Similarity |
NPD1199 |
Approved |
0.6524 |
Remote Similarity |
NPD6461 |
Clinical (unspecified phase) |
0.6522 |
Remote Similarity |
NPD5930 |
Phase 3 |
0.652 |
Remote Similarity |
NPD5903 |
Approved |
0.652 |
Remote Similarity |
NPD5902 |
Approved |
0.652 |
Remote Similarity |
NPD4986 |
Clinical (unspecified phase) |
0.651 |
Remote Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.6509 |
Remote Similarity |
NPD6340 |
Approved |
0.6509 |
Remote Similarity |
NPD6339 |
Approved |
0.6504 |
Remote Similarity |
NPD7827 |
Phase 1 |
0.6502 |
Remote Similarity |
NPD8245 |
Clinical (unspecified phase) |
0.6502 |
Remote Similarity |
NPD8359 |
Phase 2 |
0.65 |
Remote Similarity |
NPD7566 |
Clinical (unspecified phase) |
0.65 |
Remote Similarity |
NPD6238 |
Discontinued |
0.65 |
Remote Similarity |
NPD7560 |
Approved |
0.6498 |
Remote Similarity |
NPD6625 |
Approved |
0.6497 |
Remote Similarity |
NPD8330 |
Clinical (unspecified phase) |
0.6497 |
Remote Similarity |
NPD3640 |
Phase 3 |
0.6497 |
Remote Similarity |
NPD3639 |
Approved |
0.6497 |
Remote Similarity |
NPD3641 |
Approved |
0.6497 |
Remote Similarity |
NPD6030 |
Approved |
0.6497 |
Remote Similarity |
NPD6031 |
Approved |
0.6495 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6492 |
Remote Similarity |
NPD8255 |
Phase 2 |
0.6488 |
Remote Similarity |
NPD4606 |
Clinical (unspecified phase) |
0.6488 |
Remote Similarity |
NPD7620 |
Phase 2 |
0.6483 |
Remote Similarity |
NPD7284 |
Clinical (unspecified phase) |
0.6482 |
Remote Similarity |
NPD6876 |
Approved |
0.6482 |
Remote Similarity |
NPD6875 |
Approved |
0.6482 |
Remote Similarity |
NPD4675 |
Approved |
0.6482 |
Remote Similarity |
NPD4678 |
Approved |
0.6482 |
Remote Similarity |
NPD1337 |
Clinical (unspecified phase) |
0.6479 |
Remote Similarity |
NPD4515 |
Suspended |
0.6478 |
Remote Similarity |
NPD2899 |
Discontinued |
0.6471 |
Remote Similarity |
NPD5677 |
Discontinued |
0.6471
|
Remote Similarity |
NPD5718 |
Phase 2 |